Health Care [ 10/12 ] | Biotechnology [ 46/75 ]
NASDAQ | Common Stock
Decoy Therapeutics Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing.
Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture peptide conjugates targeting various unmet medical needs.
The company focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology.
The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026.
Decoy Therapeutics Inc. is based in Cambridge, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 30, 26 | 43.10 Increased by +4.37 K% | -6.48 Increased by +765.12% |
| Nov 14, 25 | -1.81 Increased by +98.67% | -1.01 Decreased by -79.21% |
| Aug 12, 25 | -0.45 Increased by +99.89% | -1.02 Increased by +55.88% |
| May 14, 25 | -1.03 Increased by +99.83% | -1.03 |
| Mar 21, 25 | -1.01 Increased by +99.69% | -0.74 Decreased by -36.49% |
| Nov 29, 24 | -136.51 Increased by +85.43% | - |
| Aug 7, 24 | -427.03 Increased by +79.28% | - |
| May 9, 24 | -588.86 Decreased by -26.31 K% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 0.00 Decreased by N/A% | -8.98 M Decreased by -513.26% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -873.47 K Increased by +10.15% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -957.83 K Increased by +32.76% | Decreased by N/A% - |
| Mar 31, 25 | 0.00 Decreased by N/A% | -1.71 M Increased by +0.34% | Decreased by N/A% - |
| Dec 31, 24 | 0.00 Decreased by N/A% | -1.46 M Decreased by -66.02% | Decreased by N/A% - |
| Sep 30, 24 | 0.00 Decreased by N/A% | -972.12 K Increased by +60.20% | Decreased by N/A% - |
| Jun 30, 24 | N/A Decreased by N/A% | -1.42 M Increased by +63.26% | - - |
| Mar 31, 24 | N/A Decreased by N/A% | -1.72 M Increased by +67.88% | - - |